NextCure, Inc. (NXTC) KPIs and segments

NXTCNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30

$6.40+0.17 (+2.73%)

Close on Nov 13, 2026Market cap $29.30MP/E –Yield 0.00%

KPIs & segments

Operating metrics and segments that drive NextCure's business

Coming soon

This tab will track the numbers specific to NextCure's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?